Fei Li

机构：Nanchang University, Kunming Medical University, Fuwai Yunnan Cardiovascular Hospital, First Affiliated Hospital of Jiangxi Medical College, Jiangxi Academy of Sciences, Union Hospital, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-7765-5975

发表论文 350 篇 · 总被引 2841 次 · h-index 28

代表论文

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC (2025 · Biomarker Research · 被引 1)
High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T-cell lymphoma: A single-agent phase IIa study (2025 · Blood · 被引 1)
Efficacy and safety of rocbrutinib, the fourth generation bruton's tyrosine kinase inhibitor, in patients with BTK inhibitor pre-treated relapsed or refractory Mantle Cell Lymphoma: Results from a Phase II rock-1 trial (2025 · Blood · 被引 1)
Comparison of TAVR and SAVR in elderly patients with pure native aortic regurgitation: outcomes and midterm results (2025 · Cardiovascular Diagnosis and Therapy · 被引 1)
Sirtuin 1 deficiency mediates chronic kidney disease-induced inflammaging cardiovascular calcification (2026 · Molecular Biomedicine)
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications (2026 · Leukemia)